CEO Hanna Sjöström participates in this year’s Stanford Impact1 CEO Summit

Oct 18, 2023

Neola Medical is one of the 40 medical technology companies partnering with Stanford Biodesign to improve the health, safety and quality of life of pediatric and maternal patients globally. CEO Hanna Sjöström is on site in Palo Alto, USA and is participating together...

BioStock interviews CEO Hanna Sjöström directly from Palo Alto, USA, to hear more about the latest clinical study results and the support from Stanford

Oct 16, 2023

Neola Medical recently opened an office in Palo Alto, Silicon Valley, USA, ahead of the U.S. launch of the company’s medical device product Neola®, for continuous monitoring of the lungs of preterm born babies. CEO Hanna Sjöström is on site to attend the...

Stanford selects Neola Medical’s medical technology product as an important innovation for neonatal care and gives the company support to market launch through the exclusive program Impact1

Oct 12, 2023

Press communication Lund, Sweden, October 12, 2023 This is a translation of the Swedish press release published 2023-10-12 Neola Medical is one of the few companies that have been selected to receive support from the Stanford University (Stanford) Impact1 program. The...

New successful results from clinical study on 100 newborn babies with Neola Medical’s medical device

Oct 10, 2023

Press communication Lund, Sweden, October 10, 2023 This is a translation of the Swedish press release published 2023-10-09 At the jENS conference in Italy on September 23, 2023, the clinical researcher and neonatologist Jurate Panaviene presented new results and...

Captivating investor presentation at the Redeye Medtech Seminar 2023

Sep 28, 2023

If you missed CEO Hanna Sjöström’s captivating investor presentation at the Redeye Medtech Seminar, you’re in luck! Catch up on all the cutting-edge insights and innovations in the world of medical technology for preterm born babies by clicking the...

CEO Hanna Sjöström comments Q2 report 2023 in new article by BioStock

Aug 17, 2023

As Neola Medical reports its second quarter of 2023, much of the focus is on market preparations. Intensive work is underway with technical verification studies while the company is also preparing for both a preclinical and a clinical study. BioStock contacted CEO...